Literature DB >> 6454749

Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. IX. Characterization of Idiotype-specific effector-phase suppressor cells on plaque-forming cell responses in vitro.

D H Sherr, M E Dorf.   

Abstract

The ability of T suppressor cells, induced by the intravenous injection of 4-hydroxy-3-nitrophenyl acetyl (NP)-modified syngeneic spleen cells, to affect an ongoing B cell response was studied in vitro. It was found that the expression of NPb idiotype-positive B cells could be selectively inhibited by the addition of antigen-induced suppressor cells in the last 24 h of the in vitro culture. This effector-phase suppression of B cell responses was antigen specific and mediated by an Lyt 1-, Lyt 2+, idiotype-binding, T cell population whose suppressive function was restricted by genes linked to the Igh locus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454749      PMCID: PMC2186186          DOI: 10.1084/jem.153.6.1445

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  DNP-Lys-ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells.

Authors:  R Sharon; P R McMaster; A M Kask; J D Owens; W E Paul
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  Idiotypic analysis of the response of C57BL/6 mice to the (4-hydroxy-3-nitrophenyl)acetyl group.

Authors:  R S Jack; T Imanishi-Kari; K Rajewsky
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

Authors:  M G Mage; L L McHugh; T L Rothstein
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

5.  Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

6.  Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells.

Authors:  C Waltenbaugh; J Thèze; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

7.  Presence on idiotype-specific suppressor T cells of receptors that interact with molecules bearing the idiotype.

Authors:  F L Owen; S T Ju; A Nisonoff
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

8.  T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells.

Authors:  M Feldmann; P C Beverley; J Woody; I F McKenzie
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

9.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Suppression by autogenous complementary idiotypes: the priority of the first response.

Authors:  D A Rowley; H Köhler; H Schreiber; S T Kaye; I Lorbach
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  14 in total

1.  Induction of suppressor cells by staphylococcal enterotoxin B: identification of a suppressor cell circuit in the generation of suppressor-effector cells.

Authors:  M Holly; Y S Lin; T J Rogers
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

2.  Abnormalities of third-order suppressor T cells in old (New Zealand black x New Zealand white) F1 mice.

Authors:  K Okuda; S Nagaoka; K Katoh; K Matsunaga; Y Ishigatubo; M Minami; K Tani
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

3.  Suppressor lymphocytes induced by epicutaneous sensitization of UV-irradiated mice control multiple immunological pathways.

Authors:  S E Ullrich; G K Yee; M L Kripke
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

4.  Analysis of T cell hybridomas. IV. Characterization of inducible suppressor cell hybridomas.

Authors:  M Minami; K Okuda; S Furusawa; M E Dorf
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

5.  An idiotype-specific helper population that bears immunoglobulin, Ia, and Lyt-1 determinants.

Authors:  D H Sherr; M E Dorf
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

6.  Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses.

Authors:  D H Sherr; M Minami; K Okuda; M E Dorf
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

7.  The role of I-J and Igh determinants on F1-derived suppressor factor in controlling restriction specificity.

Authors:  M Minami; I Aoki; N Honji; C R Waltenbaugh; M E Dorf
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

8.  Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC-315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells.

Authors:  G L Milburn; R G Lynch
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

9.  Analysis of T cell hybridomas. II. Comparisons among three distinct types of monoclonal suppressor factors.

Authors:  K Okuda; M Minami; M Furusawa; M E Dorf
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

10.  T lymphocyte-mediated suppression of myeloma function in vitro. IV. Generation of effector suppressor cells specific for myeloma idiotypes.

Authors:  A K Abbas; M Takaoki; M I Greene
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.